Metatron ($MRNJ) Announces New Additions To The Growing CBD Product Line Of CBD Infused Drinks And Edibles
August 01 2017 - 7:00AM
InvestorsHub NewsWire
Dover,
DE -- August 01, 2017 -- InvestorsHub NewsWire -- Metatron
(OTC
PINK: MRNJ), an emerging pioneer
of releasing Marijuana & CBD-related apps on iTunes and Google
Play, is pleased to announce it has secured a deal that brings a
line of full spectrum products into the Metatron line of CBD
products.
Our
newest addition to the CBD product line will add Edible
Gummies,Candies,tinctures,oils as well as capsule forms of CBD
products. Our CBD Candy and Gummies are infused and NOT dipped or
coated and provide a full spectrum profile of all cannabinoids and
terpenes naturally found within the highest grade, naturally high
CBD, medicinal cannabis strains. We have the most potent and
powerful THC free CBD formulations in the world. Our THC free full
spectrum oils provide the largest amount of naturally present
cannabinoids and diverse terpenoids in the world.
“This
newest addition to the Metatron product line will expedite
Metatron's entry into the Cannabis Health and Wellness area by
giving such a diverse product line to add to our CBD infused
Coffee's and Tea's. This newest addition places us well into the
mainstream of the burgeoning Cannabis business. This is a direction
into profitability for the Company and will increase shareholder
value he added,” stated CEO Joe Riehl.
Metatron will update
soon on when and where these products can be purchased by the
consuming public. Metatron has completed its new Corporate website
and updates and company information can be found there. The
completion of this website is just one more step in Metatron moving
towards being a major player in the Cannabis Industry. Shareholders
and potential investors can access the website here
http:// metatroninc.com/
The company is also pleased to announce a formal offer to Buzzlink,
a cannabis e-commerce platform for dispensaries and
consumers. Buzzlink.com
will be financed partially by the issuance of preferred B series
shares. For more information, please visit
http:// metatroninc.com/series-b/
or
http://www.metatronstock.com/.
Metatron approved investors can acquire Series B shares in blocks
of various sizes and recently increased discounts. The first round
investors will receive the highest discount. Series B shares can be
redeemed through the Company, are immune to reverse splits, and
will convert at 1 B share to 50,000 common shares. Details
available at
http://metatroninc.com/series- b/
or
http://www.metatronstock.com.
Metatron's Apps:
iTunes:
https://itunes.apple.com/us/artist/i-mobilize-inc./id325075390
Google Play:
https://play.google.com/store/apps/developer?
id=Metatron+Inc
Facebook:
http://www.facebook.com/metatroninc
Twitter:
http://twitter.com/metatroninc
News:
http://metatroninc.com/blog
Forward-Looking Statements:
Any statements made in this press release which are not historical
facts contain certain forward-looking statements, as such term is
defined in the Private Litigation Reform Act of 1995, concerning
potential developments affecting the business, prospects, financial
condition and other aspects of the company to which this release
pertains. These forward-looking statements involve known and
unknown risks, uncertainties and other factors that may cause our
actual results of the specific items described in this release, and
the company's operations generally, to differ materially from what
is projected in such forward-looking statements. Although such
statements are based upon the best judgments of management of the
company as of the date of this release, significant deviations in
magnitude, timing and other factors may result from business risks
and uncertainties including, without limitation, the company's need
for additional financing, which is not assured and which may result
in dilution of shareholders, the company's status as a small
company with a limited operating history, dependence on third
parties and the continuing popularity of the iOS operating system,
general market and economic conditions, technical factors, receipt
of revenues, and other factors, many of which are beyond the
control of the company. Although we believe that the expectations
reflected in the forward-looking statements are reasonable, we
cannot guarantee future results, levels of activity, performance,
or achievements. Moreover, neither we nor any other person assumes
responsibility for the accuracy and completeness of such
statements, and we disclaim any obligation
to update information contained in any forward-looking statement.
Metatron does not grow, sell or distribute any substances that
violate United States Law or the Controlled Substances
Act.
Metatron, Inc.
Joe Riehl
302-861-0431
ir@metatroninc.com
SOURCE:
Metatron, Inc.
Metatron (PK) (USOTC:MRNJ)
Historical Stock Chart
From Jun 2024 to Jul 2024
Metatron (PK) (USOTC:MRNJ)
Historical Stock Chart
From Jul 2023 to Jul 2024